共 50 条
- [31] Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodiesANNALS OF ONCOLOGY, 2015, 26 (12) : 2375 - 2391Naidoo, J.Page, D. B.Li, B. T.Connell, L. C.Schindler, K.Lacouture, M. E.Postow, M. A.Wolchok, J. D.
- [32] The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 TherapyJOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)Tunger, AntjeSommer, UlrichWehner, RebekkaKubasch, Anne SophieGrimm, Marc-OliverBachmann, Michael PhilippPlatzbecker, UweBornhaeuser, MartinBaretton, GustavoSchmitz, Marc
- [33] Treatment Beyond Progression After Anti-PD-1 Blockade in Hepatocellular CarcinomaCANCER RESEARCH COMMUNICATIONS, 2023, 3 (09): : 1912 - 1916Lim, MirMuquith, MaisharaMiramontes, BernadetteEspinoza, MagdalenaHsiehchen, David
- [34] Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumoursNATURE, 2025, 637 (8048) : 1218 - 1227Melero, Ignaciode Miguel Luken, Mariade Velasco, GuillermoGarralda, ElenaMartin-Liberal, JuanJoerger, MarkusAlonso, GuzmanGoebeler, Maria-ElisabethSchuler, MartinKoenig, DavidDummer, ReinhardReig, MariaRodriguez Ruiz, Maria-EsperanzaCalvo, EmilianoEsteban-Villarrubia, JorgeOberoi, ArjunSabat, PaulaSoto-Castillo, Juan JoseKoster, Kira-LeeSaavedra, OmarSayehli, CyrusGromke, TanjaLaeubli, HeinzRamelyte, EgleFortuny, MartaLanda-Magdalena, AnaMoreno, IreneTorres-Jimenez, JavierHernando-Calvo, AlbertoHess, DagmarRacca, FabricioRichly, HeikeSchmitt, Andreas M.Eggenschwiler, CorinneSanduzzi-Zamparelli, MarcoVilalta-Lacarra, AnnaTrojan, JoergKoch, ChristineGalle, Peter R.Foerster, FriedrichTrajanoski, ZlatkoHackl, HubertGogolla, FalkKoll, Florestan J.Wild, PeterChun, Felix Kyoung HwanReis, HenningLloyd, PeterMachacek, MatthiasGajewski, Thomas F.
- [35] Resistance to anti-PD-1/anti-PD-L1: galectin-3 inhibition with GB1211 reverses galectin-3-induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1FRONTIERS IN IMMUNOLOGY, 2023, 14Mabbitt, JosephHolyer, Ian D.Roper, James A.Nilsson, Ulf J.Zetterberg, Fredrik R.Vuong, LyndaMackinnon, Alison C.Pedersen, AndersSlack, Robert J.
- [36] Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockadeGUT, 2019, 68 (09) : 1653 - 1666Zhu, YingYang, JingXu, DaGao, Xiao-MeiZhang, ZeHsu, Jennifer L.Li, Chia-WeiLim, Seung-OeSheng, Yuan-YuanZhang, YuLi, Jian-HuaLuo, QinZheng, YanZhao, YueLu, LuJia, Hu-LiangHung, Mien-ChieDong, Qiong-ZhuQin, Lun-Xiu
- [37] Immune cell dynamics of patients and mice with hepatocellular carcinoma treated with anti-PD-L1 plus anti-CTLA-4 combination therapyCANCER RESEARCH, 2023, 83 (07)Myojin, YutaRuf, BenjaminBenmebarek, Mohamed-RedaBauer, KylyndaTrehan, RajivCoffman, KelleyMa, ChiMonge, Cecilia B.Xie, ChangqingGreten, Tim
- [38] IL-17-induced HIF1α drives resistance to anti-PD-L1 via fibroblast-mediated immune exclusionJOURNAL OF EXPERIMENTAL MEDICINE, 2022, 219 (06):Chen, XingZhao, JunjieHerjan, TomaszHong, LingziLiao, YunLiu, CainiVasu, KommireddyWang, HanThompson, AustinFox, Paul L.Gastman, Brian R.Li, XiaoLi, Xiaoxia
- [39] TARGETING IFNβ-REGULATED SECRETORY PROFILES TO OVERCOME ACQUIRED ANTI-PD-L1 RESISTANCEJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A150 - A150Shi, YuhaoDolan, MelissaMastri, MichalisEng, KevinEbos, John
- [40] Isoformic PD-1-mediated immunosuppression underlies resistance to PD-1 blockade in hepatocellular carcinoma patientsGUT, 2023, 72 (08) : 1568 - 1580Tan, ZhiwuChiu, Mei SumYang, XinxiangYue, MingCheung, Tan ToZhou, DongyanWang, YuewenChan, Anthony Wing-HungYan, Chi WingKwan, Ka YiWong, Yik ChunLi, XinZhou, JingyingTo, Ka FaiZhu, JiyeLo, Chung MauCheng, Alfred Sze-LokChan, Stephen LamLiu, LiSong, You-QiangMan, KwanChen, Zhiwei